Serum glial fibrillary acidic protein and ubiquitin C-terminal hydrolase-L1 for diagnosis of sepsis-associated encephalopathy and outcome prognostication
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
PURPOSE We investigated the role of serum Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin C-Terminal Hydrolase-L1 (UCH-L1) in diagnosis of sepsis-associated encephalopathy(SAE), predicting prognosis and long-term quality of life with patients of sepsis. MATERIALS AND METHODS This is a prospective single center study entailed 105 patients whosuffered from sepsis from Jan 2015 to Aug 2016. Serum concentrations of GFAP and UCH-L1 for diagnosis of SAE and predicting prognosis and long-term quality of life with patients of sepsis were analyzed. RESULTS The serum concentrations of GFAP and UCH-L1 were higher in SAE group than in no-SAE group (p < .001). GFAP and UCH-L1 produced an AUC of 0.824 and 0.812 respectively for diagnosis of SAE with optimal cut-off values 0.532 ng/ml and 7.72 ng/ml respectively. The optimal cut-off values of GFAP and UCH-L1 to distinguish patients with survivors from non-survivors were 0.536 ng/ml and 8.06 ng/ml with an area under the curve of 0.773 and 0.746. Patients with a higher GFAP levels had worse long-term usual activities and patients with a higher UCH-L1 levels had more long-term pain (P = .026). CONCLUSIONS Serum concentrations GFAP and UCH-L1 early elevated and associated with sepsis-associated encephalopathy, poor prognosis and quality of life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Long-term cognitive impairment after critical illness
Pandharipande, P. P., Girard, T. D., Jackson, J. C., Morandi, A., Thompson, J. L., Pun, B. T., Brummel, N. E., Hughes, C. G., Vasilevskis, E. E., Shintani, A. K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301372 · Cited by 2,842
Enhancing Recovery From Sepsis: A Review
Prescott, H. C., & Angus, D. C. (2018) · JAMA · doi:10.1001/jama.2017.17687 · Cited by 1,059
Hol, E. M., & Pekny, M. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2015.02.004 · Cited by 917
Long-term cerebral consequences of sepsis
Widmann, C. N., & Heneka, M. T. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70017-1 · Cited by 361
Potentially modifiable factors contributing to sepsis-associated encephalopathy
Sonneville, R., de Montmollin, E., Poujade, J., Garrouste-Orgeas, M., Souweine, B., Darmon, M., Mariotte, E., Argaud, L., Barbier, F., Goldgran-Toledano, D., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4807-z · Cited by 323
Brain Barrier Breakdown as a Cause and Consequence of Neuroinflammation in Sepsis
Danielski, L. G., Giustina, A. D., Badawy, M., Barichello, T., Quevedo, J., Dal-Pizzol, F., & Petronilho, F. (2018) · Molecular Neurobiology · doi:10.1007/s12035-016-0356-7 · Cited by 182
Mondello, S., Kobeissy, F., Vestri, A., Hayes, R. L., Kochanek, P. M., & Berger, R. P. (2016) · Scientific Reports · doi:10.1038/srep28203 · Cited by 110
Forebrain Cholinergic Dysfunction and Systemic and Brain Inflammation in Murine Sepsis Survivors
Zaghloul, N., Addorisio, M. E., Silverman, H. A., Patel, H. L., Valdés-Ferrer, S. I., Ayasolla, K. R., Lehner, K. R., Olofsson, P. S., Nasim, M., Metz, C. N., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01673 · Cited by 89
Ehler, J., Barrett, L. K., Taylor, V., Groves, M., Scaravilli, F., Wittstock, M., Kolbaske, S., Grossmann, A., Henschel, J., Gloger, M., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1850-7 · Cited by 80
Cited by
Blood GFAP as an emerging biomarker in brain and spinal cord disorders
Abdelhak, A., Foschi, M., Abu-Rumeileh, S., Yue, J. K., D’Anna, L., Huss, A., Oeckl, P., Ludolph, A. C., Kuhle, J., Petzold, A., et al. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-021-00616-3 · Cited by 807
Chu, J., Jiang, Y., Zhou, W., Zhang, J., Li, H., Yu, Y., & Yu, Y. (2022) · Human & Experimental Toxicology · doi:10.1177/09603271221133547 · Cited by 24
“Clinical and scientific studies have demonstrated that in septic patients, lower blood iron levels, greater lipid peroxide levels, and iron metabolic anomalies are closely associated with an elevated risk of distant morbidity and death, as well as of cognitive impairment.(6) To isolate iron from microbes to limit thei…”
BackgroundBaby, S., Reljic, T., Villalba, N., Kumar, A., & Yuan, S. Y. (2023) · PLOS ONE · doi:10.1371/journal.pone.0281941 · Cited by 17
“Other studies [54, 55] reported elevated glial fibrillary acidic protein and tau protein levels in SAE patients and proposed a serum cutoff value of 0.”
Background
Metadata
- Authors
- Wu, L., Ai, M.-L., Feng, Q., Deng, S., Liu, Z.-Y., Zhang, L.-N., & Ai, Y.-H.
- Venue
- Journal of Critical Care
- Publisher
- Elsevier BV
- Published
- 2019-08
- Volume
- 52
- Pages
- 172-179
- ISSN
- 0883-9441 (ISSN-L)
- OpenAlex
- W2943292842
- Cited by
- 38
- References
- 9
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.